Iodinated Contrast Media Transfer Tubing Set
PQH is the FDA product code for Iodinated Contrast Media Transfer Tubing Set, a class II device type, regulated under 21 CFR 880.5440. FDA's definition for this code reads: "The iodinated contrast media transfer set is intended to transfer iodinated contrast media from imaging bulk package contrast media in a controlled ambient environment. The transfer set is intended to be used to directly fill multiple sterile single use syringes from an imaging bulk package contrast media bulk package...". As of , FDA records hold 6 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- PQH
- Device name
- Iodinated Contrast Media Transfer Tubing Set
- FDA definition
- The iodinated contrast media transfer set is intended to transfer iodinated contrast media from imaging bulk package contrast media in a controlled ambient environment. The transfer set is intended to be used to directly fill multiple sterile single use syringes from an imaging bulk package contrast media bulk package under controlled ambient filling conditions such as a CT suite.
- Regulation
- 21 CFR 880.5440
- Device class
- Class II
- Review panel
- General Hospital
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 6
- Ingested recalls
- 0
Clearances, product code PQH
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2026 | 1 |
Applicants with the most clearances
Product code PQH| Applicant | Clearances |
|---|---|
| Medrad, Inc. | 2 |
| Bayer U.S., LLC | 1 |
| Bracco Injeneering S.A. | 1 |
| Mallinckrodt, Inc. | 1 |
| Ulrich GmbH & Co. KG | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
